NVS FDA calendar & decision history Novartis AG · no upcoming catalyst on file · 8 past FDA decisions
FDA decision history (8) Mar 13, 2026✓ Approved COSENTYX (secukinumab)- (SUNSH Nov 24, 2025✓ Approved FDA decision Sep 30, 2025✓ Approved FDA decision Jun 18, 2025✓ Approved FDA decision Apr 3, 2025✓ Approved FDA decision Mar 28, 2025✓ Approved FDA decision Mar 20, 2025✓ Approved FDA decision Jan 29, 2025✓ Approved FDA decision See the full 2026 PDUFA calendar → This page aggregates NVS's FDA catalysts from pdufa.bio's own calendar and decision archive. Each item links to its source page. Facts and dates only; verify against primary FDA / SEC / company filings.
Not affiliated with or endorsed by the FDA. pdufa.bio is an independent service; "FDA", "PDUFA", and all company, drug, and ticker names are used descriptively and remain the property of their owners. Informational and educational only — not investment advice. Data and historical statistics only; no trade recommendations and no individual-drug approval probabilities. Verify every date and outcome against primary FDA / SEC / company filings. © 2026 pdufa.bio